13 completed, 1 recruiting. 14 Phase 3, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 14 | Completed 13, Recruiting 1 |
| Phase 2 | 1 | Completed 1 |
Follow vaxigrip: new trials by email Literature Review of vaxigrip trials Research Report on vaxigrip
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Analysis of Growth Differentiation Factor 15 (GDF-15), Mid Regional proAdrenomedullin (MR proADM), and Persepsin Levels in Patient in Acute Coronary Syndrome Patients With Pneumonia, With or Without Influenza Vaccination Vaxigrip, antibiotic treatments, percutaneus coronary intervention - Acute Coronary Syndromes (ACS), Pneumonia | Phase 3 | Recruiting | University of Brawijaya | 60 | 2026-01-01 | 2026-05-22 |
| Trial of Tolerability, Safety and Immunogenicity of the Flu-M Vaccine in Children Between 6 Months and 9 Years Old Flu-M, Inactivated split influenza vaccine 0.5 mL, Vaxigrip, Inactivated split influenza vaccine 0.5 mL, Flu-M, Inactivated split influenza vaccine 0.25 mL - Influenza, Human, Vaccination; Infection | Phase 3 | Completed | St. Petersburg Research Institute of Vaccines and Sera | 1066 | 2021-02-16 | 2022-07-22 |
| Study to Evaluate Immunogenicity, Safety, and Tolerability of ZOSTAVAX™ Vaccine (Zoster Vaccine Live, V211) Administered Concomitantly Versus Nonconcomitantly With Quadrivalent Influenza Virus Vaccine (Inactivated) in Participants ≥50 Years of Age (V211-062) ZOSTAVAX™, Placebo to ZOSTAVAX™, Influenza Vaccine - Herpes Zoster | Phase 3 | Completed | Merck Sharp & Dohme LLC | 882 | 2015-09-11 | 2018-10-30 |
| Immunogenicity and Safety of Different Dosing Schedules of Trivalent Influenza Vaccine in HIV-infected Pregnant Women Trivalent influenza vaccine (seasonal), Normal saline - Influenza | Phase 3 | Completed | University of Witwatersrand, South Africa | 800 | 2012-09-01 | 2015-01-12 |
| The Clinical Trial Protocol for the Influenza Virus Vaccine (Split Virion, Inactivated) Influenza Virus Vaccine, Influenza Virus Vaccine(contains Preservative) - Influenza | Phase 3 | Completed | Institute of Medical Biology, Chinese Academy of Medical Sciences | 1200 | 2012-03-01 | 2023-10-11 |
| The Clinical Trial Protocol for the Influenza Virus Vaccine (Split Virion, Inactivated) （Children Forms of Drug） Influenza Virus Vaccine(no Preservative ), Influenza Virus Vaccine(contains Preservative) - Influenza | Phase 3 | Completed | Institute of Medical Biology, Chinese Academy of Medical Sciences | 1200 | 2012-03-01 | 2023-10-11 |
| Influenza Vaccine Trial in HIV Uninfected Pregnant Women Trivalent influenza vaccine, Normal saline - Influenza | Phase 3 | Completed | University of Witwatersrand, South Africa | 2116 | 2011-03-03 | 2018-08-06 |
| Influenza Vaccination of HIV Infected Pregnant Women: Safety and Immunogenicity Trivalent influenza vaccine, Normal saline - Influenza | Phase 2 / Phase 3 | Completed | University of Witwatersrand, South Africa | 194 | 2011-03-01 | 2013-02-07 |
| Field Trial of Maternal Influenza Immunization in Asia influenza vaccine, saline placebo - Influenza Human | Phase 3 | Completed | Children's Hospital Medical Center, Cincinnati | 3693 | 2010-11-01 | 2022-02-01 |
| Clinical Trial of the Inactivated Influenza Vaccine (0.25ml Formulation for Pediatric Use) Influenza Split Vaccine, Inactivated Influenza Vaccine - Influenza | Phase 3 | Completed | Hualan Biological Engineering, Inc. | 810 | 2009-03-01 | 2012-09-06 |
| Influenza Vaccine Dose-Response in Infants and Toddlers: Immunogenicity and Reactogenicity Inactivated Influenza Vaccine Trivalent Types A and B (Split Virion) - Influenza | Phase 3 | Completed | British Columbia Centre for Disease Control | 262 | 2008-08-01 | 2011-08-04 |
| Study of Inactivated, Split-Virion Influenza Vaccine Compared With the Reference Vaccine Vaxigrip® in the Elderly Inactivated, split-virion influenza vaccine - Orthomyxoviridae Infection, Influenza | Phase 3 | Completed | Sanofi Pasteur, a Sanofi Company | 3707 | 2006-09-01 | 2014-01-14 |
| Lot-to-Lot Consistency Study of the Investigational, Inactivated, Split-Virion Influenza Vaccine in Adults Inactivated Split-virion influenza vaccine - Orthomyxoviridae Infection, Influenza | Phase 3 | Completed | Sanofi Pasteur, a Sanofi Company | 2256 | 2006-09-01 | 2014-01-14 |
| A Study of an Investigational Zoster Vaccine in Subjects With a History of Varicella (Chickenpox) Given Concomitantly With Another Vaccine (V211-011) ZOSTAVAX™ (concomitant), Comparator: Influenza Vaccine, ZOSTAVAX™ (Nonconcomitant) - Herpes Zoster | Phase 3 | Completed | Merck Sharp & Dohme LLC | 763 | 2005-09-01 | 2015-09-21 |
Influenza, Human (12) · Herpes Zoster (2) · Orthomyxoviridae Infections (2) · Acute Coronary Syndrome (1) · Hepatitis E (1) · Infections (1) · Pneumonia (1) · Pulmonary Disease, Chronic Obstructive (1) · Whooping Cough (1)
University of Witwatersrand, South Africa (3) · Institute of Medical Biology, Chinese Academy of Medical Sciences (2) · Merck Sharp & Dohme LLC (2) · Sanofi Pasteur, a Sanofi Company (2) · British Columbia Centre for Disease Control (1) · Children's Hospital Medical Center, Cincinnati (1) · Hualan Biological Engineering, Inc. (1) · St. Petersburg Research Institute of Vaccines and Sera (1) · University of Brawijaya (1)
China (3) · South Africa (3) · France (2) · Lithuania (2) · Belgium (1) · Canada (1) · Indonesia (1) · Italy (1) · Nepal (1) · Russia (1) · Spain (1) · United Kingdom (1)
Guoyang Liao, Ph. D (2) · Keith P Klugman, MD, PhD (2) · Shabir A Madhi, MD, PhD (2) · Yuliang Zhao, MD (2) · Adriana Weinberg (1) · Adriana Weinberg, PhD (1) · Danuta M Skowronski, MD (1) · Ellina Ruzanova, PhD (1) · Feng-cai Zhu, M.D. (1) · Mark C Steinhoff, MD (1) · Shabir A Madhi, MD PhD (1)
PMID 19261173, PMID 25184864, PMID 28369198, PMID 29253090, PMID 38743692, PMID 20372053, PMID 21768314, PMID 21857263, PMID 25879974, PMID 27380464, PMID 28522338, PMID 28575286, PMID 28825515, PMID 28830693, PMID 28984909, PMID 29100709, PMID 29443825, PMID 29452372, PMID 31056697, PMID 31911146, PMID 32379201, PMID 32526188, PMID 32868130, PMID 32943001